Newbridge Financial Services Group’s Acceleron Pharma XLRN Stock Holding History

Newbridge Financial Services Group’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-19	Closed	-$3K	–	1589
2021 Q3	$3K	Hold	19	–	–	﹤0.01%	1158
2021 Q2	$2K	Hold	19	–	–	﹤0.01%	1318
2021 Q1	$3K	Buy	+19	New	+$2.45K	﹤0.01%	1145

Newbridge Financial Services Group's XLRN Position: Q4 2021 in Review

Newbridge Financial Services Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 19 shares — an estimated $3K sold.

Newbridge Financial Services Group first reported a position in XLRN in Q1 2021 and held it in 3 quarters. The position peaked at $3K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Newbridge Financial Services Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Newbridge Financial Services Group sold 19 Acceleron Pharma shares in Q4 2021, an estimated $3K.
Newbridge Financial Services Group first reported a position in Acceleron Pharma in Q1 2021 and held it in 3 quarters.
Newbridge Financial Services Group's Acceleron Pharma position peaked at $3K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Newbridge Financial Services Group's 13F filing for Q4 2021, filed 19 Jan 2022.